|Articles|May 1, 2003

May 2003
Volume 9
Issue 5

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Author(s)Mauro Moscucci, MD, David W. Muller, MD, Charles M. Watts, MD

Download PDF: Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Articles in this issue

over 22 years ago

Article

Lansoprazole Overutilization: Methods for Step-Down Therapy

over 22 years ago

Article

Evaluation of a Depression Health Management Program to Improve Outcomes in First or Recurrent Episode Depression

over 22 years ago

Article

A Prediction Model for Targeting Low-Cost, High-Risk Members of Managed Care Organizations

over 22 years ago

Article

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

New Dermatologic Therapies Make Waves at Maui Derm 2026